These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 15051774
1. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia. Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM. J Clin Oncol; 2004 Apr 01; 22(7):1260-7. PubMed ID: 15051774 [Abstract] [Full Text] [Related]
2. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. Boogaerts MA, Van Hoof A, Catovsky D, Kovacs M, Montillo M, Zinzani PL, Binet JL, Feremans W, Marcus R, Bosch F, Verhoef G, Klein M. J Clin Oncol; 2001 Nov 15; 19(22):4252-8. PubMed ID: 11709569 [Abstract] [Full Text] [Related]
3. High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia. Cazin B, Divine M, Leprêtre S, Travade P, Tournilhac O, Delmer A, Jaubert J, Feugier P, Dreyfus B, Mahé B, Grosbois B, Maloisel F, Eghbali H, Dumontet C, Bénichou J, Guibon O, Leleu X, Leporrier M, Maloum K. Br J Haematol; 2008 Oct 15; 143(1):54-9. PubMed ID: 18710390 [Abstract] [Full Text] [Related]
7. Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma. Tobinai K, Watanabe T, Ogura M, Morishima Y, Ogawa Y, Ishizawa K, Minami H, Utsunomiya A, Taniwaki M, Terauchi T, Nawano S, Matsusako M, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Hayashi M, Seriu T, Hotta T. J Clin Oncol; 2006 Jan 01; 24(1):174-80. PubMed ID: 16330664 [Abstract] [Full Text] [Related]
8. Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration. Laurenti L, Tarnani M, De Padua L, Efremov DG, Zini G, Garzia M, Piccirillo N, Chiusolo P, Sorà F, Innocenti I, Sica S, Leone G. Ann Hematol; 2008 Nov 01; 87(11):891-8. PubMed ID: 18587576 [Abstract] [Full Text] [Related]
9. Efficacy of oral fludarabine in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Zhu Y, Qin Q, Xie Z. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Mar 01; 38(3):221-4. PubMed ID: 23545817 [Abstract] [Full Text] [Related]
12. Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. Hainsworth JD, Vazquez ER, Spigel DR, Raefsky E, Bearden JD, Saez RA, Greco FA. Cancer; 2008 Mar 15; 112(6):1288-95. PubMed ID: 18189296 [Abstract] [Full Text] [Related]
13. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma. Hagenbeek A, Eghbali H, Monfardini S, Vitolo U, Hoskin PJ, de Wolf-Peeters C, MacLennan K, Staab-Renner E, Kalmus J, Schott A, Teodorovic I, Negrouk A, van Glabbeke M, Marcus R. J Clin Oncol; 2006 Apr 01; 24(10):1590-6. PubMed ID: 16575010 [Abstract] [Full Text] [Related]
14. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study. Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J. Ann Hematol; 1991 Jul 01; 63(1):1-4. PubMed ID: 1715191 [Abstract] [Full Text] [Related]